- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05365516
Medical Safety Huddles - a Multi-site QI Project
May 24, 2023 updated by: University Health Network, Toronto
Medical Safety Huddles - a Multi-site QI (Quality Improvement) Project
This quality improvement project will implement and evaluate the impact of physician-specific huddles, termed "medical safety huddles" on patient safety within four programs/sites at Sinai Health Systems, St. John's Rehab (Sunnybrook) and University Health Network.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
4
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1X5
- Mount Sinai Hospital
-
Toronto, Ontario, Canada, M2M 2G1
- St John's Rehab
-
Toronto, Ontario, Canada, M4M 2B5
- Bridgepoint Active Health
-
-
Ontario1
-
Toronto, Ontario1, Canada, M5G2A2
- Princess Margaret Hospital - UHN
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion criteria:
- Any staff physicians, residents or medical students working at the four programs/sites
Exclusion criteria:
None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Medical Safety Huddles - Pre-implementation
|
|
|
Experimental: Medical Safety Huddles - Post-implementation
|
These short, virtual huddles are led by a huddle leader and occur on a weekly or once every two week basis.
Each site will be adapting the Medical Safety Huddles for their context and workflow to specifically engage physicians.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adverse events
Time Frame: 19 months
|
We will examine whether the huddles impact the frequency and severity of adverse events experienced by patients.
We will also determine if the huddles specifically impact certain types of adverse events in terms of frequency and severity.
We will also perform analysis specific for each program/site.
|
19 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Process measure - Attendance rate
Time Frame: 15 months
|
The number of physicians attending each huddle will be monitored to ensure the fidelity of implementation
|
15 months
|
|
Process measure - Safety issues
Time Frame: 15 months
|
The type and number of safety issues brought up during huddles will be monitored on a monthly basis to ensure the fidelity of implementation
|
15 months
|
|
Process measure - Actions taken to address safety issues
Time Frame: 15 months
|
The number of actions taken to address safety issues will be monitored on a monthly basis to ensure the fidelity of implementation
|
15 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Meiqi Guo, MD, University Health Network, Toronto
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2020
Primary Completion (Actual)
October 31, 2022
Study Completion (Actual)
January 30, 2023
Study Registration Dates
First Submitted
April 20, 2022
First Submitted That Met QC Criteria
May 3, 2022
First Posted (Actual)
May 9, 2022
Study Record Updates
Last Update Posted (Actual)
May 25, 2023
Last Update Submitted That Met QC Criteria
May 24, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 19-6357
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.